SSNC

SS&C Technologies Holdings, Inc.

Next est. report 2026-10-22 · BMO

Loading…

Overview

SS&C Technologies Holdings, Inc. offers software and Technology-Enabled Services to financial and healthcare industries globally. Its solutions automate complex

SS&C Technologies Holdings, Inc. offers software and Technology-Enabled Services to financial and healthcare industries globally. Its solutions automate complex processes such as investment accounting, fund administration, and claims management. Revenue is primarily from Technology-Enabled Services (85.4%), catering to diverse financial firms, wealth managers, and healthcare providers like Humana, leveraging AI for innovation and efficiency.

What They Do (Plain English & Analogies): SS&C Technologies acts as a specialized support system for complex financial and healthcare businesses. Imagine these companies as high-performance operations with many intricate parts, such as managing investments, processing insurance claims, or handling sensitive patient data. SS&C provides the essential software and services – the specialized tools and skilled technicians – that keep these critical functions running smoothly. They automate the detailed 'back-office' and 'middle-office' tasks, like calculating taxes, reconciling accounts, processing claims, and ensuring compliance with strict rules and regulations globally. By efficiently handling these critical, often behind-the-scenes operations, SS&C allows its clients to focus on their main business goals. The company is also increasingly integrating advanced artificial intelligence to make these processes even faster, more efficient, and more secure, helping clients navigate new digital frontiers like tokenized investments and automated workflows.
Very Brief History: SS&C Technologies Holdings, Inc. was founded in 1986 by William C. Stone in Windsor, Connecticut. The company celebrated its 40-year anniversary in the first quarter of 2026. It went public in 1996, was taken private in 2005, and then relisted on NASDAQ in 2010. Over its history, SS&C has expanded significantly through both organic growth and numerous strategic acquisitions, extending its reach across fund administration, wealth management, and healthcare sectors.
"Street Stereotype": SS&C is generally perceived as a vital provider of back-end infrastructure for financial and legal compliance. It is widely recognized for its deep involvement in the extensive 'paperwork' and audit trails associated with large-scale M&A and private equity deal-making, offering essential software and services to ensure these complex transactions and ongoing operations adhere to regulatory and administrative requirements.
Subsidiaries On Linked In*: SS&C GlobeOp — LinkedIn: SS&C GlobeOp
Black Diamond Wealth Platform — LinkedIn: Black Diamond Wealth Platform
Blue Prism — LinkedIn: Blue Prism
Intralinks — LinkedIn: Intralinks
Calastone — LinkedIn: Calastone
SS&C Advent — LinkedIn: SS&C Advent
SS&C Salentica — LinkedIn: Salentica
SS&C Tier1 — Mentioned as a subsidiary by PitchBook, specific LinkedIn page not readily found but implies a distinct entity.
Curo — Acquired end of 2025, provides additional exposure in EMEA.; LinkedIn: Curo
Customer Sectors & Example Clients: SS&C's customers primarily operate within the financial services and healthcare industries. In financial services, their clientele includes hedge funds, private equity funds, mutual funds, asset managers, wealth managers, family offices, prime brokers, insurance and pension funds, multinational banks, commercial lenders, brokers/dealers, municipal finance groups, and real estate lenders and property managers. Specific examples of clients and partners mentioned include Humana (a major US healthcare provider, utilizing the DomaniRx platform), Insignia (a significant superannuation fund in Australia), and large global macro funds.
New Customers / Segments They'Re Targeting: SS&C is actively targeting new customers and expanding its market share in several key areas. This includes the substantial $4 trillion Australian superannuation market, where they are making significant inroads. They also see tremendous opportunities for growth in North America and Europe. In the healthcare sector, SS&C is expanding its presence with platforms like DomaniRx, which is making inroads at large healthcare institutions. Furthermore, the company is focused on capturing more market share in digital investment markets through Calastone Technologies, particularly in areas like tokenization of different asset classes. The Wealth business is also targeting RIAs whose clients are moving assets into trusts, providing a tailwind for their Trust Suite offerings.
Supply Chain And Sourcing Geographies: SS&C Technologies primarily delivers software and software-enabled services, meaning its 'supply chain' is largely intellectual and digital. This encompasses proprietary data streams and deep domain expertise developed internally. Software development is carried out by its global workforce, which comprises approximately 29,000 employees worldwide. The company operates its own private cloud and data center infrastructure, which are ISO and SOC certified to ensure redundancy and robust cybersecurity. While specific geographic locations of these data centers are not detailed, their global presence across the Americas, Europe, Asia, Africa, and Australia implies a distributed infrastructure to serve clients in these regions. Additionally, SS&C's growth strategy heavily involves acquiring other technology companies, such as UK-based Blue Prism and Calastone, and US-based Advent Software, effectively sourcing intellectual property and talent globally.
Sales Geographies And Expansion Plans: SS&C currently sells its products and services on a global scale, with operations spanning the United States, the United Kingdom, Europe, the Middle East, Africa, the Asia Pacific region (including Japan), Canada, and the broader Americas. Management has indicated plans to expand sales and market share in several key areas, specifically in North America and Europe due to robust demand and healthy pipelines, and in the Australian superannuation market, building on recent successes. They are also focused on capturing more market share in digital investment markets through Calastone Technologies and expanding their presence in the healthcare sector with platforms like DomaniRx.
How Key Themes May Help/Hurt: SS&C is a constituent of the 'Software '26: Legal Tech' theme, and its business model is well-positioned to benefit from several aspects of this theme. The company's deep domain expertise in financial and healthcare compliance, coupled with its focus on AI integration and a 'governance first' approach, aligns with the demand for 'fiduciary-grade AI' and solutions for increasing regulatory complexity. SS&C's platforms, which handle complex regulatory filings and tax returns globally, are essential for legal and financial compliance, a core aspect of the theme. The launch of Blue Prism WorkHQ for Agentic automation and investments in tokenization (Calastone) demonstrate its commitment to leveraging AI and new technologies to drive efficiency and expand its market, directly benefiting from accelerated AI integration and productivity gains. However, SS&C could be hurt by slower-than-anticipated AI adoption and change management, as financial and healthcare industries, like legal, can be risk-averse. While SS&C is confident in its AI strategy, the 'resistance to change' among some professionals could slow the adoption of new AI-enabled systems. Intensifying competition from generic LLMs and AI startups could also pose a long-term risk, although SS&C emphasizes its deep embeddedness and specialized expertise as a differentiator. Macroeconomic headwinds, such as geopolitical conflicts and tariffs, also present a general risk to client investment decisions.

3 Main Long-Term Bull Details

Leadership in AI and Digital Investment Technologies: SS&C is strategically leveraging AI as a structural tailwind, deploying Agentic automation through platforms like Blue Prism WorkHQ and integrating AI across its products and operations with a governance-first approach. Its acquisition of Calastone further positions it as a leader in digital investment markets, including tokenized funds and digital cash settlement, expanding its addressable market and capturing future growth in fintech innovation.
Robust Organic Growth and Diversified Business Model: The company consistently demonstrates strong adjusted organic revenue growth, driven by new business wins, multiyear renewals, and the resilience of its diversified business model across financial services and healthcare. Key segments like Global Investor and Distribution Services (GIDS) and SS&C GlobeOp continue to perform strongly, and the company's assets under administration (AUA) have seen significant growth, underscoring its market leadership and ability to expand client relationships.
Strong Cash Generation and Shareholder Returns: SS&C consistently generates substantial cash flow from operating activities, enabling significant capital allocation to shareholder returns. Share repurchases remain a top capital allocation priority, demonstrating management's confidence in the company's valuation and commitment to enhancing shareholder value, alongside a clear path to margin expansion with a target of 40% EBITDA margin in Q4 2026.

3 Main Long-Term Bear Details

Exposure to Macroeconomic Headwinds and Market Volatility: Despite its resilience, SS&C remains exposed to macroeconomic headwinds such as geopolitical conflicts, tariffs, and spiking oil prices, which can lead to client hesitancy in investment decisions and technology upgrades. As a company deeply tied to financial markets, prolonged downturns or instability could negatively impact asset values, M&A deal volumes (affecting Intralinks), and overall demand for its services.
Integration Risks and Debt from Acquisitions: While acquisitions are a key growth driver, SS&C has historically incurred significant debt to fund these deals. The ongoing challenge of successfully integrating numerous acquired companies and realizing anticipated synergies and returns carries inherent operational and financial risks, including the need to actively explore refinancing opportunities for maturing bonds.
Pace of AI Adoption and Competition: While SS&C is investing heavily in AI, the large-scale deployment and successful client adoption of new AI-enabled platforms carry execution risks. The traditionally risk-averse financial and healthcare industries may adopt new technologies at a slower pace, and the rapidly evolving technology landscape could intensify competition from more agile competitors or clients opting for in-house AI solutions, potentially challenging SS&C's market position.

Competitors And Differentiation: SS&C differentiates itself through its deep domain expertise, strong trusted client relationships, and constant innovation guided by its 'Customer Zero strategies'. Its platforms are deeply embedded in clients' day-to-day operations, serving as systems of record and execution, which makes SS&C a natural partner for clients advancing their AI strategies and provides protection against disintermediation. The company serves the largest and most sophisticated firms globally, with its platforms growing alongside their complex businesses. SS&C emphasizes its expertise in internal controls and reconciliation, viewing itself as a company of 'accountants and systems people' who understand the importance of detailed and arcane regulatory compliance. The company also makes significant strategic acquisitions, such as Blue Prism and Calastone, to be leaders in desired technologies rather than merely 'dabbling'.
Recent Performance & What The Market'S Focused On: SS&C delivered strong first-quarter 2026 results, underscoring its resilience despite macro headwinds like a war in Iran, tariffs, and spiking oil prices. The company reported adjusted revenue of $1.648 billion, up 9% year-over-year, and adjusted diluted earnings per share of $1.69, a 14% increase. Adjusted consolidated EBITDA reached a Q1 record of $651 million, up 10%. Adjusted organic revenue growth was 5%, driven by GIDS (10.4% growth) and GlobeOp (6.7% growth). SS&C also added $581 billion in assets under administration to its fund administration business since Q1 2024. The company returned $233 million to shareholders in Q1, prioritizing share repurchases. For the full year 2026, SS&C raised its guidance, expecting revenue between $6.664 billion and $6.824 billion, with 5.3% organic revenue growth at the midpoint, and adjusted diluted EPS between $6.74 and $7.06. The market is focused on SS&C's progress towards its target of a 40% adjusted consolidated EBITDA margin by Q4 2026, continued Assets Under Administration (AUA) growth, client adoption and revenue contribution from AI-enabled platforms like Blue Prism WorkHQ and tokenized investment solutions (Calastone), sustained adjusted organic revenue growth, and the magnitude and consistency of its share repurchase program.

Revenue Segments And Estimated Mix: Adjusted Revenue — Mix: $1,696.9 million; Source: Q2 2026 earnings call; Trend: Up 10.3% year-over-year, record for Q2. Adjusted organic revenue growth was 7.6%.
Technology-Enabled Services — Mix: Largest segment; Source: Q1 2026 earnings call; Trend: New name for largest revenue line item to better reflect deeply embedded technology framework powering services business. Encompasses proprietary data streams, domain expertise, software, private cloud, data center infrastructure, and services like NAV computations, tax returns, regulatory filings, investor interactions, risk calculations. Software represents 11% of this category.
Global Investor and Distribution Solutions (GIDS) — Mix: Significant contributor to growth; Source: Q2 2026 earnings call; Trend: Underlying growth still in excess of 5% (excluding lift-outs like Insignia). Strong pipeline.
SS&C GlobeOp — Mix: Significant contributor to growth; Source: Q2 2026 earnings call; Trend: Strong quarter, indicative of strength in hedge fund business. Assets under administration up $581 billion over the last 2 years.
Intralinks (Virtual Data Rooms) — Mix: Contributor to growth; Source: Q2 2026 earnings call; Trend: Strengthening business, positive metrics (pipeline, bookings, revenue), alternatives LP communication growing steadily.
Wealth Business (Black Diamond and related products) — Mix: Growing segment; Source: Q1 2026 earnings call; Trend: Expected to continue to grow in excess of double digits.
Healthcare — Mix: Growing segment; Source: Q2 2026 earnings call; Trend: DomaniRx platform processed nearly 3 million claims for Medicare GLP-1 Bridge Program with Humana. Optimistic about future growth.
License renewals — Mix: Lumpy contributor to organic growth; Source: Q2 2026 earnings call; Trend: Contributed to higher organic growth in Q2 2026 due to a couple of big renewals hitting in the quarter.
Product Brands: SS&C GlobeOp
Global Investor and Distribution Solutions (GIDS)
Intralinks
Black Diamond Wealth Platform
Blue Prism
Blue Prism WorkHQ
Calastone
SS&C Retirement Solutions
Bluedoor
Advent Outsourcing Services
Advent Data Solutions
ALPS Advisors
DomaniRx
Salentica
Salentica Engage
Salentica Elements
Geneva
Moxy
Advent Portfolio Exchange (APX)
SS&C Singularity
SS&C Skyline
SS&C BenefiX
SS&C Innovest Trust
Genesis
Eclipse
DBC
AI guardrails product

Bull / Bear Details

SS&C Technologies, a leading provider of mission-critical software and technology-enabled services for financial and healthcare industries, demonstrated strong

Thesis

SS&C Technologies, a leading provider of mission-critical software and technology-enabled services for financial and healthcare industries, demonstrated strong Q1 2026 results despite macro headwinds, raising 2026 guidance. The company is strategically integrating AI, expanding market opportunities in digital investments and healthcare, and prioritizing shareholder returns. Its diversified model and innovation leadership make the long-term investment case compelling as of 2026-07-26.

Bull case

SS&C delivered strong Q1 2026 results with 5% adjusted organic revenue growth, driven by GIDS (10.4%) and GlobeOp (6.7%), and acquisitions exceeding expectations. The company added $581 billion in AUA since Q1 2024, demonstrating market leadership. Significant opportunities in the $4 trillion Australian superannuation market and strengthening Intralinks business further expand its addressable markets.
SS&C views AI as a structural tailwind, leveraging it to enhance software development, accelerate implementations, and drive efficiencies. The upcoming launch of Blue Prism WorkHQ, an Agentic workflow orchestration platform, and the successful internal deployment of digital workers (saving hundreds of millions annually) highlight its innovation leadership and ability to monetize AI.
The company raised its full-year 2026 guidance for revenue, EBITDA, and EPS, targeting 50 basis points of EBITDA margin expansion and a 40% margin in Q4. SS&C returned $233 million to shareholders in Q1 2026, including $168 million in share repurchases, and prioritizes buybacks, demonstrating strong cash generation and commitment to shareholder value.

Bear case

Persistent macroeconomic headwinds, including geopolitical conflicts, tariffs, and spiking oil prices, continue to pose risks. These factors can lead to client hesitancy in investment decisions and technology upgrades, potentially impacting future revenue growth and creating an unpredictable operating environment despite SS&C's demonstrated resilience.
While SS&C is aggressively pursuing AI integration, the traditionally risk-averse financial and healthcare industries may adopt new technologies at a slower pace. Resistance to change among professionals, coupled with the high cost of compute and larger data infrastructure for AI, presents execution risks and could delay widespread monetization.
The rapidly evolving technology landscape intensifies competition, requiring continuous innovation and significant investment in R&D and data infrastructure. While SS&C is a leader, the high costs associated with maintaining its competitive edge in AI and digital solutions, alongside potential competition from agile startups, could pressure margins or necessitate ongoing capital allocation.

Bull / Bear Case

Bear Case: SS&C Technologies faces persistent macroeconomic headwinds, including geopolitical conflicts, tariffs, and spiking oil prices, which can lead to client hesitancy in technology investments and create an unpredictable operating environment. A significant concern is the company's high net debt, approximately $7.3 billion, and a net debt to EBITDA ratio of around 2.75x, which increases financial risk, particularly in a high-interest-rate environment and poses refinancing challenges. While SS&C is investing heavily in AI, the traditionally risk-averse financial and healthcare industries may adopt new technologies at a slower pace, delaying widespread monetization. The rapidly evolving technology landscape also intensifies competition, requiring continuous, costly R&D and infrastructure investments that could pressure margins.
Bull Case: SS&C Technologies demonstrated strong Q1 and Q2 2026 results, with adjusted organic revenue growth of 5% and 7.6% respectively, driven by key segments like GIDS (10.4% in Q1) and GlobeOp (6.7% in Q1). The company successfully added $581 billion in Assets Under Administration (AUA) since Q1 2024, showcasing market leadership. SS&C views AI as a significant structural tailwind, actively leveraging it to enhance software development, accelerate implementations, and drive efficiencies, as evidenced by the upcoming launch of Blue Prism WorkHQ and internal digital worker deployments saving hundreds of millions annually. Management raised full-year 2026 guidance for revenue, EBITDA, and EPS, targeting a 40% EBITDA margin by Q4. Strong cash generation supports substantial shareholder returns, with $435.2 million in share repurchases in Q2 2026, prioritizing buybacks and indicating confidence in its valuation and future prospects.
More Compelling & Why: Bull. Despite debt concerns, SS&C's current EV/EBITDA of approximately 10.81x to 11.5x is significantly below the sector median of around 15x, suggesting undervaluation. The strongest argument for the bull case is the company's consistent operational outperformance, robust organic growth, and aggressive share repurchase program, demonstrating management's confidence and commitment to shareholder value. My view would flip if SS&C's organic revenue growth decelerates significantly below guidance or if there are clear signs of distress in managing its substantial debt load.

Key Factors5 rows

Key Factor	Why It Matters	What To Watch	What It Signals	Where/How To Track	Free Alt Data	Paid Alt Data
Magnitude and Consistency of Share Repurchases	This demonstrates management's confidence in the company's valuation and future cash flow generation, directly enhancing shareholder value by reducing diluted shares outstanding and boosting EPS.	Monitor the total dollar amount of shares repurchased in Q3 2026 and subsequent quarters. Compare this to the record $435.2 million spent in Q2 2026. Also, observe any changes in management's commentary regarding capital allocation priorities (e.g., shift away from buybacks).	Bullish if share repurchases remain robust, maintaining or exceeding Q2 2026 levels, and management reiterates conviction in buybacks as the top capital allocation priority. Bearish if repurchase activity significantly declines without clear, highly accretive acquisition opportunities.	SS&C Technologies Holdings, Inc. earnings releases and conference call transcripts (next expected Q3 2026 earnings call in late October/early November 2026), Form 10-Q filings.	SEC EDGAR filings for Form 10-Q (for share count and repurchase details).	Bloomberg Terminal/Refinitiv Eikon: Share repurchase data.
Adjusted Organic Revenue Growth (overall, GIDS, and Intralinks, including impact of large license renewals)	This indicates the underlying health and competitive strength of SS&C's core businesses, reflecting demand for its technology and services and the success of AI integration efforts.	Monitor reported adjusted organic revenue growth in Q3 2026 relative to the 5% midpoint guidance, and the full-year 2026 guidance of 5.5% at the midpoint. Track commentary on the timing and impact of large license renewals and the sequential strengthening of the Intralinks business.	Bullish if adjusted organic revenue growth consistently exceeds the 5% Q3 2026 guidance and full-year 5.5% midpoint guidance. Bullish if Intralinks continues to strengthen sequentially. Bearish if growth rates decline significantly below guidance or show decelerating trends.	SS&C Technologies Holdings, Inc. earnings releases and conference call transcripts (next expected Q3 2026 earnings call in late October/early November 2026).	Industry reports on M&A activity (for Intralinks); hedge fund performance indices (e.g., HFRX Global Hedge Fund Index) and asset flows.	Thinknum: SS&C client count changes (proxy for new business wins); Similarweb: Web traffic trends for SS&C product pages (e.g., Intralinks, GlobeOp).
Assets Under Administration (AUA) Growth and Fund Administration Business Health	AUA is a key indicator of SS&C's market share and client retention in its core fund administration business, which generates recurring revenue. Strong AUA growth signals continued client trust and market leadership.	Monitor management commentary on AUA growth in future earnings calls, specifically looking for updates on the $581 billion added since Q1 2024. Track the hedge fund redemption index (e.g., SS&C's Capital Movements Index) and new client mandates in fund administration.	Bullish if AUA continues to grow robustly, driven by new client wins and market appreciation, and if the hedge fund redemption index remains low (e.g., below 1.5%). Bullish if SS&C reports increased market share in strategic regions like Australia. Bearish if AUA growth decelerates significantly or if there's a lack of new, large fund administration mandates.	SS&C Technologies Holdings, Inc. earnings releases and conference call transcripts (next expected Q3 2026 earnings call in late October/early November 2026).	Industry reports on hedge fund asset flows (e.g., from Preqin, HFR); SS&C's own Capital Movements Index (if publicly available).	eVestment: Hedge fund flows data; Preqin: Private capital market data.
Client Adoption and Revenue Contribution from AI-enabled Platforms (WorkHQ, DomaniRx) and Tokenized Investment Solutions (Calastone)	This validates SS&C's strategic investments in AI and digital assets, demonstrating its ability to capture new market opportunities, drive efficiencies, and maintain a competitive edge in evolving financial and healthcare tech landscapes.	Look for management commentary on client wins, deployment scale, and quantifiable benefits (e.g., number of claims processed by DomaniRx for Humana, new clients added to Calastone network, WorkHQ implementations). Specifically, track Calastone's 2026 growth relative to the mid-teens expectation.	Bullish if management reports strong uptake of WorkHQ for Agentic automation, continued growth in Calastone clients (exceeding 431 new clients), and successful expansion of digital cash settlement capabilities. Bullish if DomaniRx continues to process high volumes of claims for new or expanded programs. Bearish if adoption is slow or if significant security/governance concerns are highlighted.	SS&C Technologies Holdings, Inc. earnings releases and conference call transcripts (next expected Q3 2026 earnings call in late October/early November 2026), company press releases.	Google Trends: 'tokenized investments,' 'Agentic AI automation,' 'DomaniRx' search volume; Industry news on digital asset adoption and healthcare program updates.	Thinknum: Job postings for AI/ML roles at SS&C (indicating investment); Apptopia/Sensor Tower: App downloads/usage for relevant SS&C client-facing apps (if applicable).
Progress Towards 40% Adjusted Consolidated EBITDA Margin Target by Q4 2026	This indicates SS&C's operational efficiency, cost control, and ability to leverage investments in technology and AI to improve profitability, directly impacting earnings and valuation.	Track adjusted consolidated EBITDA margin reported in Q3 2026 and specifically the Q4 2026 margin. Monitor core expense growth relative to revenue growth and management commentary on AI-driven efficiency gains.	Bullish if EBITDA margin shows consistent expansion, reaching or exceeding the 40% Q4 2026 target and the 50 basis point annual expansion goal. Bullish if management highlights significant margin improvements from AI agent adaptation. Bearish if margin expansion stalls or declines, indicating challenges in cost control or leveraging investments.	SS&C Technologies Holdings, Inc. earnings releases and conference call transcripts (next expected Q3 2026 earnings call in late October/early November 2026).	N/A (internal metric).	N/A (internal metric).

Key Reported Metrics, Reratings Triggers & Results3 rows

As a key profitability metric, Adjusted Diluted EPS reflects the company's efficiency in converting revenue into earnings per share, crucial for shareholder val

Key reported metrics
Metric	Last period	Why it matters
Adjusted Diluted EPS	18.1%	As a key profitability metric, Adjusted Diluted EPS reflects the company's efficiency in converting revenue into earnings per share, crucial for shareholder value and indicating effective cost management.
Adjusted Organic Revenue Growth	7.6%	This metric indicates the underlying health and competitive strength of SS&C's core business, reflecting the success of its offerings and AI integration efforts. Investors watch it for sustainable growth.
Adjusted Consolidated EBITDA Growth	11.7%	EBITDA growth is a key indicator of operational profitability and efficiency, reflecting the company's ability to expand earnings before interest, taxes, depreciation, and amortization. It is crucial for assessing margin expansion goals.

Key Questions

Will SS&C's adjusted organic revenue growth for Q2 2026 meet or exceed its 5.6% midpoint guidance, demonstrating continued resilience amidst macroeconomic headw

Will SS&C's adjusted organic revenue growth for Q2 2026 meet or exceed its 5.6% midpoint guidance, demonstrating continued resilience amidst macroeconomic headwinds?

Question 2: Can SS&C effectively monetize its investments in AI-enabled platforms like the newly launched Blue Prism WorkHQ and new technologies such as Calastone's tokenized investment solutions, translating them into significant new client wins and expanded market share over the next quarter?
Question 3: Will SS&C maintain its prioritized share repurchase program at a significant level in Q2 2026, and can it continue to expand its adjusted consolidated EBITDA margin towards its 40% Q4 target amidst ongoing investments in R&D and AI infrastructure?

Earnings Transcript Summary2 rows

2026-07-23 · 2026Q2 Earnings Call

3 Things Management Is Most Focused On	Call Takeaway & Tone	Prior Quarter'S Y/Y Growth By Segment	3 Things Analysts Most Pressed On (And Mgmt Responses)	Revenue Segments
1. AI Integration and Innovation: Management is heavily focused on deploying AI across products and operations, highlighting its role in growth and margin expansion, and emphasizing a 'governance first' approach. They are leveraging acquisitions like Blue Prism and Calastone to lead in technologies like Agentic AI and tokenized investment products. 2. Shareholder Returns and Capital Allocation: Share repurchases remain the top capital allocation priority, with a record quarterly buyback of $435.2 million, leading to a 4% reduction in diluted shares outstanding year-over-year. 3. Client Service, Retention, and Market Expansion: SS&C is focused on strong customer relationships, multiyear renewals, and expanding market share globally, as evidenced by new business wins, the performance of acquisitions like Curo and Calastone, and the successful launch of the Medicare GLP-1 Bridge Program with Humana.	The overall takeaway of the call was highly positive and confident. SS&C reported a record-setting Q2 2026, with record highs in adjusted revenue, adjusted EBITDA, earnings per share, and shares repurchased. Management expressed optimism about the resilience of their diversified business model, the value clients place on their technology, and the strategic advantages gained from recent acquisitions and AI integration. The tone was upbeat, emphasizing strong execution, robust pipelines, and a commitment to shareholder value, despite a cautious approach to future guidance.	Adjusted revenue (Q1 2026): 9% year-over-year growth. Adjusted organic revenue growth (Q1 2026): 5% year-over-year growth. Global Investor and Distribution Solutions (GIDS) (Q1 2026): 10.4% year-over-year growth. SS&C GlobeOp (Q1 2026): 6.7% year-over-year growth. Intralinks (Q1 2026): 3.2% year-over-year growth.	1. Organic Growth Drivers and Sustainability: Analysts inquired about the drivers behind the strong organic growth, particularly the impact of large license renewals and market/transaction activity. Management explained that license renewals, which are lumpy due to contract cycles, significantly contributed to the higher organic growth, and noted the strength of the hedge fund business indicated by a low redemption index. 2. Demand for Outsourcing and AI Adoption: Analysts asked if demand for outsourcing, especially in GlobeOp, was picking up due to companies needing to modernize for AI. Management affirmed that strong demand is driven by SS&C's tech-forward position and ability to deploy Agentic capabilities scalably, which customers prefer over building internally. 3. Q3 Organic Growth Guidance and Capitalized Software Spend: Analysts questioned the implied step-down in Q3 organic growth guidance and the concentration of capitalized software spend. Management stated that the pipeline is full of opportunities, including renewals, and they are being consistent in their guidance. They also detailed investments in new systems like Genesis, Eclipse, DBC, DomaniRx, WorkHQ, and AI guardrails, expecting similar capitalized software and R&D investment levels to persist.	Adjusted revenue: 10.3% year-over-year growth. Adjusted organic revenue growth: 7.6% year-over-year. Global Investor and Distribution Services (GIDS) underlying growth (excluding lift-outs): in excess of 5%. Intralinks (virtual data room): reported a nice sequential increase in organic growth and business strengthening. No specific year-over-year growth percentages were provided for GlobeOp or the overall front, middle, and back-office technology business in Q2 2026.

2026-04-23 · 2026Q1 Earnings Call

3 Things Management Is Most Focused On	Call Takeaway & Tone	Prior Quarter'S Y/Y Growth By Segment	3 Things Analysts Most Pressed On (And Mgmt Responses)	Revenue Segments
1. AI Integration and Innovation: Management is heavily focused on leveraging AI to enhance software development, increase speed to market, accelerate implementations, improve customer experience, and drive efficiencies. They are launching Blue Prism WorkHQ, an Agentic workflow orchestration platform, and view AI as a structural tailwind for the business. 2. Shareholder Returns: SS&C is prioritizing share repurchases, with $168 million spent in Q1 2026, and also pays common stock dividends, returning 98% of allocated capital to shareholders in Q1. 3. Client Service and Market Expansion: Management emphasizes disciplined attention to clients, leading to new logo wins and upsell/cross-sell activity. They are making strides in the Australian superannuation market with GIDS and see tremendous opportunities in North America and Europe.	The overall takeaway of the call was highly positive and confident. Despite significant macro headwinds, SS&C delivered strong first-quarter results, including record adjusted revenue, adjusted diluted EPS, and adjusted consolidated EBITDA. Management raised 2026 guidance, underscoring their optimism and the resilience of their business. A key theme was the strategic integration and leveraging of AI, both for internal efficiencies and new client offerings, with the upcoming launch of Blue Prism WorkHQ. The company also emphasized its commitment to shareholder returns through share repurchases and dividends, and highlighted continued growth and market opportunities in key segments like GIDS and Wealth.	Adjusted revenue (Q4 2025): 8.1% year-over-year growth. Adjusted organic revenue growth (Q4 2025): 5.3% year-over-year growth. Global Investor and Distribution Solutions (GIDS) (Q4 2025): 13.2% year-over-year growth. SS&C GlobeOp (Q4 2025): 9.6% year-over-year growth. Intralinks (Q4 2025): Specific year-over-year growth for Q4 2025 was not explicitly detailed in the provided search results. Healthcare (full year 2025): Struggled with a 3.3% decline (Q4 2025 specific growth not found).	1. Impact of Macro Headwinds: Analysts questioned if results would have been stronger without macro headwinds (war in Iran, tariffs, spiking oil prices). Management responded that despite these challenges, SS&C delivered strong results, underscoring its resilience, and clients continue to invest in necessary technology. 2. Private Credit Risk and Redemptions: Analysts inquired about potential risks from private credit redemptions, especially given current topicality. Management clarified that most private credit funds are closed-end structures, making their fees fairly static and largely immune from day-to-day fluctuations, and major clients continue to grow. 3. AI as a Threat/Disruption: Analysts asked which segments have the most risk from AI and which are most protected. Management stated they do not view AI as a threat, but rather an enabler. They highlighted their deep embeddedness in client operations, handling complex regulatory filings globally, and their expertise in internal controls as protection against disintermediation. They also mentioned the Blue Prism acquisition and internal deployment of digital workers.	Adjusted revenue: 9% year-over-year growth. Adjusted organic revenue growth: 5% year-over-year. Global Investor and Distribution Solutions (GIDS): 10.4% year-over-year growth. SS&C GlobeOp: 6.7% year-over-year growth. Intralinks: 3.2% year-over-year growth. Wealth business (Black Diamond): continues to grow in excess of double digits. Healthcare: posted a nice turnaround this quarter (specific percentage not provided).

Transcript Tidbits3 rows

2026-07-23

About Expanding Eligible Market	About Competition	About The Broader Industry	Where Things Are Headed	Updates On Theme	Broader Themes Emerging	Bullish-Leaning Quotes (Short)	Bearish-Leaning Quotes (Short)	Hiring
SS&C's Curo acquisition has provided additional exposure in EMEA, with revenues growing nicely. Calastone is performing ahead of expectations, having added 431 clients to its network. The company is investing in solutions for digital investment markets, including supporting tokenized investment products and enabling digital investment transactions to settle using regulated forms of digital cash, such as stable coins and tokenized commercial bank deposits, to reduce settlement risk, improve operational efficiency, and simplify cross-border transactions. The Medicare GLP-1 Bridge Program, launched on July 1, has processed nearly 3 million claims using SS&C's DomaniRx platform for Humana, demonstrating the technology's scale, reliability, and flexibility, and expanding access to important therapies for millions of Americans. Demand for outsourcing is picking up, particularly as companies look to modernize with AI. SS&C's Global Investor and Distribution Services (GIDS) business has a strong pipeline and is winning mandates in Australia, Europe, and North America. The Intralinks business is strengthening, with positive trends in opportunities, bookings, and revenue, driven by success in virtual data rooms and alternatives LP communication.	SS&C's global footprint remains a competitive advantage, with offerings spanning markets and asset classes worldwide. Rahul Kanwar stated, "we're tech forward and we're the biggest player in this business, and we have a lot of referenceability." Established enterprises are increasingly choosing SS&C to move their automation efforts to Agentic AI, rather than building solutions internally. Bill Stone highlighted the company's strong market position by quoting a prospect, "you guys have 65% market share. I'm pretty sure you can probably handle us." He also emphasized that SS&C made significant investments in acquisitions like Blue Prism ($1.6 billion) and Calastone ($1 billion) to be leaders in desired technologies, not to "dabble" or be "also ran."	The company continues to operate in an "uncertain backdrop," but rapid technological innovation, particularly with AI, is driving customers towards SS&C as they seek partners to leverage the latest technologies. There is growing interest in tokenized investment products, with clients and prospects actively seeking the necessary infrastructure for digital transactions. The highly anticipated Medicare GLP-1 Bridge Program launched on July 1. The hedge fund business is currently very strong, with the redemption index at 1.35%, which is near its historical low since 2009. Assets under administration in SS&C's fund administration business have increased by $581 billion over the last two years. M&A market activity is a contributing factor to the Intralinks business. AI is a prominent topic for executives and boards, who are keenly interested in its application. Highly regulated businesses necessitate robust governance and protection, especially concerning AI deployment.	SS&C expects Calastone's 2026 growth to be in the mid-teens. The company's innovation roadmap includes extending to the next stage of the digital investment life cycle, enabling digital investment transactions to settle using regulated forms of digital cash. SS&C is on track to meet its margin objectives for the year and is deploying AI across products and operations to drive growth and margin expansion. The company is actively exploring refinancing opportunities for bonds maturing in 2027 to optimize its capital structure. For Q3 2026, revenue is expected to be in the range of $1.657 billion to $1.697 billion, with 5% organic revenue growth at the midpoint. Full-year 2026 expectations have been increased, with revenue projected between $6.672 billion and $6.832 billion and 5.5% organic revenue growth at the midpoint. Targeted EBITDA growth is 9.3%, with a 50 basis point EBITDA margin expansion aiming for a 40% margin in Q4. Cash from operating activities is expected to be between $1.717 billion and $1.817 billion. Adjusted net income is projected to be in the range of $1.67 billion to $1.77 billion, and adjusted diluted EPS is expected to be between $6.93 and $7.25, representing approximately 15.5% growth at the midpoint. The company plans a stronger weighting towards share repurchases over debt reduction. SS&C's pipeline is full of opportunities, including renewals, suggesting potential for outperformance. Similar levels of capitalized software and R&D investment are anticipated, alongside material improvements to margins through the adaptation of AI agents and other technologies. The Intralinks business is expected to continue strengthening throughout the remainder of the year.	Legal	Digital investment markets, tokenized investment products, digital cash settlement (including stable coins and tokenized commercial bank deposits), Agentic AI and automation, and AI governance and protection in highly regulated businesses.	Q2 was record-setting for SS&C. Our strong quarter resulted in setting quarterly records for second quarter in revenue, adjusted EBITDA, earnings per share and shares repurchased. We continue to demonstrate success in an uncertain backdrop, underscoring the resilience of our diversified business model and the value clients place on our technology, expertise and innovation. The acquisitions we completed at the end of 2025 are both tracking ahead of expectations. We look forward to capturing more market share. Our second quarter results came in ahead of expectations with strong sales and renewal performance and continued margin expansion. Our global footprint remains a competitive advantage. Our pipeline is full of opportunities. There are some renewals coming up as well. So we have opportunities to outperform. We believe our results speak to the strength of our business and consistency of our execution.	It's a 6-month program, Kevin. So knock on wood, they -- it's the government. So will they stick with a very successful program? That's probably 50-50.	Bill Stone mentioned that SS&C gained "1,400 people when we got Blue Prism, and we got another 250 and probably added another 25 with Calastone," referring to workforce expansion through acquisitions.

2026-04-23

About Expanding Eligible Market	About Competition	About The Broader Industry	Where Things Are Headed	Updates On Theme	Broader Themes Emerging	Bullish-Leaning Quotes (Short)	Bearish-Leaning Quotes (Short)	Hiring
SS&C's recent acquisitions are executing ahead of expectations, strengthening global capabilities and expanding addressable markets. The company has added $581 billion in assets under administration to its fund administration business since Q1 2024. In Australia, the superannuation market is $4 trillion, offering significant growth potential, and SS&C is actively working to grow its market share there. Tremendous opportunities are also seen in North America and Europe. Intralinks grew 3.2% with positive leading indicators and increasing adoption of its next-generation AI-enabled deal center platform. In healthcare, the market is enormous, with GLP-1s being a big deal and Domani making inroads. The Wealth business, primarily Black Diamond, is seeing tailwinds from Trust Suite as customers move assets through trusts, and the Morningstar transaction added 600-700 more RIAs.	SS&C is deeply embedded in client operations, serving as systems of record and execution, which makes it a natural partner for clients advancing AI strategies and provides protection against disintermediation. The company serves the largest and most sophisticated firms globally, with platforms growing alongside their complex businesses. SS&C's growth of $581 billion in AUA since Q1 2024 positions it very high in league tables. The company has almost all large global macro funds, which are receiving increasing allocations. SS&C acquired Calastone for $1 billion, indicating a strategic investment to deliver services to clients and gain market share.	The first quarter of 2026 was marked by macro headwinds including a war in Iran, tariffs, and spiking oil prices. The industry is entering its next phase of technology transformation driven by AI. Regulatory compliance, such as filing tax returns, Qs, annual statements, and adhering to specific rules from exchanges and ministries of finance globally, remains a constant and detailed requirement. Private credit is a topical area, but SS&C's exposure is primarily to closed-end fund structures, making its fees fairly static and immune from day-to-day fluctuations. Equity markets, including NASDAQ and S&P 500, have been robust, and hedge funds have shown stronger performance. The healthcare market is enormous, with new medicines and therapies like GLP-1s driving growth. There is an industry-wide challenge of older systems on Wall Street and resistance to change among some professionals.	SS&C is raising its 2026 guidance due to strong performance and visibility. The company is leveraging AI to enhance software development, increase speed to market, accelerate implementations, improve customer experience, and drive efficiencies, supporting both revenue opportunities and cost leverage. SS&C remains bullish on its opportunities, viewing AI as a structural tailwind. The company's pipelines are robust, with execution being a priority. SS&C will launch Blue Prism WorkHQ, an Agentic workflow orchestration platform, next week. The company expects GIDS to perform very well in 2026 and Black Diamond to continue growing in excess of double digits. SS&C aims for an annual EBITDA expansion of 50 basis points, targeting a 40% margin in Q4 2026, and is prioritizing share repurchases over debt reduction.	SS&C	AI-driven technology transformation, macro-economic headwinds (geopolitical conflicts, tariffs, inflation), tokenization of asset classes, and blockchain technology.	We delivered strong first quarter results, underscoring SS&C's resilience. We are raising 2026 guidance. We remain bullish on our opportunities and continue to be AI as a structural tailwind for our business. SS&C's pipelines are robust. I would guess that GIDS is going to do very well in 2026. Black Diamond continues to execute, and it's got a lot of very strong and satisfied clients. And we would guess it's going to continue to grow in excess of double digits. We really believe we had a strong quarter. We believe we have really a lot of momentum.	The first quarter of 2026 included a war in Iran, tariffs war, spiking oil prices and other macro headwinds. You get hesitancy, Kevin, as you well know, right, when you have tariffs flying out at billions and billions and billions. And then you have war and then you have spiking oil prices, which generally is going to increase inflation. So there's a lot of macro headwinds. A lot of people in their 40s don't want to change systems because they want to wait until they retire.	SS&C has grown its workforce in Australia to over 3,000 people. The deployment of close to 4,000 digital workers, improved by turning them into AI agents, has potentially saved the company a couple of hundred million dollars a year, indicating AI's role in driving efficiency and potentially impacting human roles.

2026-04-23

About Expanding Eligible Market	About Competition	About The Broader Industry	Where Things Are Headed	Updates On Theme	Broader Themes Emerging	Bullish-Leaning Quotes (Short)	Bearish-Leaning Quotes (Short)	Hiring
SS&C's recent acquisitions are performing better than expected, enhancing global capabilities and broadening addressable markets. The company has added $581 billion in assets under administration to its fund administration business since Q1 2024. The Australian superannuation market, valued at $4 trillion, presents significant growth potential where SS&C is actively working to expand its market share. Intralinks saw 3.2% growth, supported by positive leading indicators and increased adoption of its next-generation AI-enabled deal center platform. In the healthcare sector, the market is described as 'enormous,' with GLP-1s being a significant driver and the Domani platform making inroads. The Wealth business, primarily Black Diamond, is benefiting from the Trust Suite as clients increasingly move assets through trusts, and the Morningstar transaction added 600-700 more RIAs. SS&C also sees tremendous opportunities in North America and Europe.	SS&C's platforms are deeply embedded in clients' day-to-day operations, acting as systems of record and execution, which positions the company as a natural partner for clients advancing their AI strategies and offers protection against disintermediation. The company serves the largest and most sophisticated firms globally, with its platforms evolving alongside their increasingly complex businesses. The addition of $581 billion in AUA since Q1 2024 places SS&C very high in league tables. SS&C holds nearly all large global macro funds, which are receiving increasing allocations from various allocators, pension funds, and insurance companies. The company does not view AI as a threat due to its deep embeddedness in client processes, emphasizing that it is very difficult to replace human judgment, trust, and years of delivery in solving complex problems. SS&C acquired Calastone for $1 billion, demonstrating a strategic investment to lead in desired technologies rather than 'dabbling'.	The first quarter of 2026 was characterized by macro headwinds, including a war in Iran, tariffs, and spiking oil prices. The industry is entering its next phase of technology transformation, driven by AI. Regulatory compliance, such as filing tax returns, Qs, annual statements, and adhering to specific rules from exchanges and ministries of finance globally, remains a constant and detailed requirement. Private credit is a topical area, but SS&C's exposure is primarily to closed-end fund structures, which makes its fees fairly static and immune from day-to-day fluctuations. Equity markets, including NASDAQ and S&P 500, have been robust, and hedge funds have shown stronger performance over the past couple of quarters. The healthcare market is enormous, with new medicines and therapies like GLP-1s driving growth. There is an industry-wide challenge of older systems on Wall Street and resistance to change among some professionals, with many in their 40s preferring to delay system changes until retirement.	SS&C is raising its 2026 guidance due to strong performance and visibility. The company is leveraging AI to enhance software development, increase speed to market, accelerate implementations, improve customer experience, and drive efficiencies, supporting both revenue opportunities and cost leverage over time. SS&C remains bullish on its opportunities, viewing AI as a structural tailwind. The company's pipelines are robust, with execution being a priority. SS&C will launch Blue Prism WorkHQ, an Agentic workflow orchestration platform, next week. Management anticipates GIDS will perform very well in 2026 and expects the Wealth business (Black Diamond) to continue growing in excess of double digits. For Q2 2026, revenue is expected to be between $1.64 billion and $1.68 billion, with 5.6% organic revenue growth at the midpoint. For the full year 2026, revenue is projected between $6.664 billion and $6.824 billion, with 5.3% organic revenue growth at the midpoint, targeting an annual EBITDA expansion of 50 basis points and a 40% margin in Q4.	Legal	AI-driven technology transformation, macro-economic headwinds (geopolitical conflicts, tariffs, inflation), tokenization of asset classes, and blockchain technology.	We delivered strong first quarter results, underscoring SS&C's resilience. We are raising 2026 guidance. We remain bullish on our opportunities and continue to be AI as a structural tailwind for our business. SS&C's pipelines are robust. I would guess that GIDS is going to do very well in 2026. Black Diamond continues to execute, and it's got a lot of very strong and satisfied clients. And we would guess it's going to continue to grow in excess of double digits. We really believe we had a strong quarter. We believe we have really a lot of momentum.	The first quarter of 2026 included a war in Iran, tariffs war, spiking oil prices and other macro headwinds. You get hesitancy, Kevin, as you well know, right, when you have tariffs flying out at billions and billions and billions. And then you have war and then you have spiking oil prices, which generally is going to increase inflation. So there's a lot of macro headwinds. A lot of people in their 40s don't want to change systems because they want to wait until they retire.

Upcoming EventsTable

Catalyst ID	Estimated Timing	Estimated Date Start	Estimated Date End	Catalyst	Why It Matters	Ticker Or Theme Specific	Transcript Date	Source Type
SSNC_01ebcf99	It's a 6-month program	2026-12-31	2026-12-31	Completion of the 6-month Medicare GLP-1 Bridge Program.	The successful conclusion of this program could lead to its extension or similar government contracts, validating SS&C's DomaniRx platform's scalability and potentially driving future healthcare revenue.	Ticker	2026-07-23	earnings_transcript